Melanocytic tumors express connexin 43 but not 26: immunohistochemical analysis with potential significance in melanocytic oncogenesis. 2013

Michael R Sargen, and Rachel H Gormley, and Terri L Pasha, and Sabrina Yum, and Geza Acs, and Xiaowei Xu, and Paul J Zhang
*Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA †Department of Neurology, Children Hospital of Philadelphia, Philadelphia, PA ‡Department of Pathology, Moffitt Cancer Center, Tampa, FL.

Connexins (Cx) are structural proteins that form gap junctions, which are vital to cell-cell communication and help to regulate cell division. The purpose of this study was to evaluate if there are diagnostically important differences in immunostaining for connexins 43 (Cx43) and 26 (Cx26) in melanoma compared with nevi. Formalin-fixed paraffin-embedded sections of 34 histologically well-characterized melanocytic lesions, 17 primary malignant melanomas (MM), and 17 nevi were stained with a polyclonal antibody to Cx43 and a polyclonal antibody to Cx26. Immunoreactivity in tumor cells was evaluated semiquantitatively based on extent (1%-100%) and intensity (0-3) of reactivity. A score of 0-300 was generated by the product of the extent and intensity readings in each case. Significantly higher Cx43 immunoreactivity was detected in MM (mean intensity score = 253.5; 95% confidence interval, 227.9-279.2; P = 0.002) compared with nevi (mean intensity score = 152.4; 95% confidence interval, 104.9-199.8). In contrast, Cx26 immunoreactivity was less than 5% or entirely absent in all melanocytic tumors (n = 34). The significantly higher Cx43 staining in MM when compared with nevi suggests an oncogenic role for this protein in melanocytic tumor progression. Consequently, the evaluation of immunohistochemical staining for Cx43 in conjunction with other ancillary stains and tumor histology may be helpful in distinguishing MM from nevi, although positive Cx26 reactivity suggests that a cutaneous neoplasm is of nonmelanocytic origin.

UI MeSH Term Description Entries
D007150 Immunohistochemistry Histochemical localization of immunoreactive substances using labeled antibodies as reagents. Immunocytochemistry,Immunogold Techniques,Immunogold-Silver Techniques,Immunohistocytochemistry,Immunolabeling Techniques,Immunogold Technics,Immunogold-Silver Technics,Immunolabeling Technics,Immunogold Silver Technics,Immunogold Silver Techniques,Immunogold Technic,Immunogold Technique,Immunogold-Silver Technic,Immunogold-Silver Technique,Immunolabeling Technic,Immunolabeling Technique,Technic, Immunogold,Technic, Immunogold-Silver,Technic, Immunolabeling,Technics, Immunogold,Technics, Immunogold-Silver,Technics, Immunolabeling,Technique, Immunogold,Technique, Immunogold-Silver,Technique, Immunolabeling,Techniques, Immunogold,Techniques, Immunogold-Silver,Techniques, Immunolabeling
D008545 Melanoma A malignant neoplasm derived from cells that are capable of forming melanin, which may occur in the skin of any part of the body, in the eye, or, rarely, in the mucous membranes of the genitalia, anus, oral cavity, or other sites. It occurs mostly in adults and may originate de novo or from a pigmented nevus or malignant lentigo. Melanomas frequently metastasize widely, and the regional lymph nodes, liver, lungs, and brain are likely to be involved. The incidence of malignant skin melanomas is rising rapidly in all parts of the world. (Stedman, 25th ed; from Rook et al., Textbook of Dermatology, 4th ed, p2445) Malignant Melanoma,Malignant Melanomas,Melanoma, Malignant,Melanomas,Melanomas, Malignant
D009508 Nevus, Pigmented A nevus containing melanin. The term is usually restricted to nevocytic nevi (round or oval collections of melanin-containing nevus cells occurring at the dermoepidermal junction of the skin or in the dermis proper) or moles, but may be applied to other pigmented nevi. Nevus, Melanocytic,Nevi, Melanocytic,Nevi, Pigmented,Pigmented Moles,Melanocytic Nevi,Melanocytic Nevus,Pigmented Nevi,Pigmented Nevus
D002471 Cell Transformation, Neoplastic Cell changes manifested by escape from control mechanisms, increased growth potential, alterations in the cell surface, karyotypic abnormalities, morphological and biochemical deviations from the norm, and other attributes conferring the ability to invade, metastasize, and kill. Neoplastic Transformation, Cell,Neoplastic Cell Transformation,Transformation, Neoplastic Cell,Tumorigenic Transformation,Cell Neoplastic Transformation,Cell Neoplastic Transformations,Cell Transformations, Neoplastic,Neoplastic Cell Transformations,Neoplastic Transformations, Cell,Transformation, Cell Neoplastic,Transformation, Tumorigenic,Transformations, Cell Neoplastic,Transformations, Neoplastic Cell,Transformations, Tumorigenic,Tumorigenic Transformations
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000072259 Connexin 26 A gap junction protein encoded by the Gap Junction Beta 2 or GJB2 gene. In the cochlea and epidermis, its hexamers form channels between cells that open to allow cell-to-cell diffusion of small molecules as well as recycling of potassium. Mutations in Connexin 26 are associated with congenital SENSORINEURAL HEARING LOSS. Connexin Cx26,Connexin beta-2,Gap Junction beta-2 protein,beta2 Connexin,26, Connexin,Connexin beta 2,Connexin, beta2,Cx26, Connexin,Gap Junction beta 2 protein,beta-2, Connexin
D012878 Skin Neoplasms Tumors or cancer of the SKIN. Cancer of Skin,Skin Cancer,Cancer of the Skin,Neoplasms, Skin,Cancer, Skin,Cancers, Skin,Neoplasm, Skin,Skin Cancers,Skin Neoplasm
D017630 Connexins A group of homologous proteins which form the intermembrane channels of GAP JUNCTIONS. The connexins are the products of an identified gene family which has both highly conserved and highly divergent regions. The variety contributes to the wide range of functional properties of gap junctions. Connexin,Connexin Complex Proteins,Gap Junction Proteins,Gap Junction Channel Proteins,Gap Junction Protein,Junction Protein, Gap,Junction Proteins, Gap
D018031 Connexin 43 A 43-kDa peptide which is a member of the connexin family of gap junction proteins. Connexin 43 is a product of a gene in the alpha class of connexin genes (the alpha-1 gene). It was first isolated from mammalian heart, but is widespread in the body including the brain. Cx43,Connexin43

Related Publications

Michael R Sargen, and Rachel H Gormley, and Terri L Pasha, and Sabrina Yum, and Geza Acs, and Xiaowei Xu, and Paul J Zhang
December 2019, Veterinary sciences,
Michael R Sargen, and Rachel H Gormley, and Terri L Pasha, and Sabrina Yum, and Geza Acs, and Xiaowei Xu, and Paul J Zhang
October 2000, The Journal of comparative neurology,
Michael R Sargen, and Rachel H Gormley, and Terri L Pasha, and Sabrina Yum, and Geza Acs, and Xiaowei Xu, and Paul J Zhang
March 2017, Zhonghua nan ke xue = National journal of andrology,
Michael R Sargen, and Rachel H Gormley, and Terri L Pasha, and Sabrina Yum, and Geza Acs, and Xiaowei Xu, and Paul J Zhang
July 1999, Journal of reproduction and fertility,
Michael R Sargen, and Rachel H Gormley, and Terri L Pasha, and Sabrina Yum, and Geza Acs, and Xiaowei Xu, and Paul J Zhang
November 2016, The Journal of surgical research,
Michael R Sargen, and Rachel H Gormley, and Terri L Pasha, and Sabrina Yum, and Geza Acs, and Xiaowei Xu, and Paul J Zhang
February 2012, Analytical and quantitative cytology and histology,
Michael R Sargen, and Rachel H Gormley, and Terri L Pasha, and Sabrina Yum, and Geza Acs, and Xiaowei Xu, and Paul J Zhang
March 2009, Basic research in cardiology,
Michael R Sargen, and Rachel H Gormley, and Terri L Pasha, and Sabrina Yum, and Geza Acs, and Xiaowei Xu, and Paul J Zhang
June 2023, International journal of molecular sciences,
Michael R Sargen, and Rachel H Gormley, and Terri L Pasha, and Sabrina Yum, and Geza Acs, and Xiaowei Xu, and Paul J Zhang
July 2002, Oncogene,
Michael R Sargen, and Rachel H Gormley, and Terri L Pasha, and Sabrina Yum, and Geza Acs, and Xiaowei Xu, and Paul J Zhang
January 2003, Genetic testing,
Copied contents to your clipboard!